Use of Buspirone in the Treatment of Nonpharmacological Bruxism: About 4 Cases.

Abstract

OBJECTIVE:

The aim of the study was to describe the efficacy of buspirone in controlling nonpharmacological awake and sleep bruxism.

METHODS:

Four cases of nonpharmacological awake and sleep bruxism, one of them with a 20-year-long history, in which buspirone succeeded to control bruxism, are described and discussed.

RESULTS:

Two of the 4 cases had sleep bruxism, and the other 2 cases had sleep and awake bruxism. Besides anxiety, no other predisposing condition was identified. Buspirone was effective in reducing bruxism symptoms in the 4 cases. Mean percentage of bruxism reduction after buspirone was ranked as 65% by subjects.

CONCLUSIONS:

In this small series of cases, buspirone proved effective in the control of nonpharmacological awake and sleep bruxism.

• Authors: Dora Pedroso Kowacs, Caroline Mensor Folchini, Katia Regina de Moura Vieira, Jessica A Giraldes, Pedro André Kowacs
• Journal: Clinical neuropharmacology (Clin Neuropharmacol) 2021 Nov-Dec 01 Vol. 44 Issue 6 Pg. 247-249 ISSN: 1537-162X [Electronic] United States
• PMID: 34767327 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Buspirone

Topics

• Anxiety
• Bruxism
• Buspirone (therapeutic use)
• Humans
• Sleep
• Sleep Bruxism (drug therapy)
• Wakefulness